No Data
No Data
Cantor Fitzgerald Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2.5
Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $2
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Cuts Target Price to $2
Insider Sale: See Remarks of $PACB Sells 100,773 Shares
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
Where Pacific Biosciences Stands With Analysts